Here, we conducted a case-control study to investigate whether BCC was associated with the oxidative DNA damage, hOGG1 levels, and antioxidant defense status and whether tumor removal affected the redox status of patients with BCC compared to control subjects with nonmalignant skin diseases. The gene discussed is OGG1; the disease is skin basal cell carcinoma.